Richard D. Cummings

From Wikipedia, the free encyclopedia

Dr. Richard D. Cummings is the William Patterson Timmie Professor and Chairman of the Department of Biochemistry at Emory University School of Medicine in Atlanta, Georgia. He is a co-founder, among many other well-known scientists, in the field of glycomics and glycobiology.

Before moving to Emory University, Dr. Cummings was the Ed Miller Endowed Chair in Molecular Biology, the George Lynn Cross Professor in Biochemistry, and Professor of Biochemistry and Molecular Biology at theUniversity of Oklahoma Health Science Center College of Medicine in Oklahoma City, Oklahoma.

Dr. Cummings is the co-founder, along with Dr. Rodger P. McEver, of Selexys Pharmaceutical Corporation. He also serves as President and Chief Scientific Officer. Selexys Pharmaceutical Corporation is based in Oklahoma City, Oklahoma.

Dr. Cummings received his B.S. in Biology from the University of Montevallo in 1974. He received his Ph.D. in Biochemistry from The Johns Hopkins University in 1980. He was a Postdoc Fellow in Biochemistry at Washington University in St. Louis from 1980 through 1983.